NovoCure (NVCR) News Today $17.47 +0.11 (+0.63%) As of 10:05 AM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NVCR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period NovoCure (NASDAQ:NVCR) Trading Up 6.5% - Here's WhyNovoCure (NASDAQ:NVCR) Trading 6.5% Higher - Here's What HappenedJune 10 at 2:14 PM | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Receives $32.83 Average Price Target from AnalystsJune 7, 2025 | americanbankingnews.comWedbush Estimates NovoCure's FY2026 Earnings (NASDAQ:NVCR)June 7, 2025 | americanbankingnews.comWhat is Wedbush's Estimate for NovoCure FY2026 Earnings?NovoCure Limited (NASDAQ:NVCR - Free Report) - Equities research analysts at Wedbush increased their FY2026 earnings per share estimates for shares of NovoCure in a report released on Monday, June 2nd. Wedbush analyst D. Nierengarten now anticipates that the medical equipment provider will earn (June 5, 2025 | marketbeat.comNovoCure (NASDAQ:NVCR) Sees Strong Trading Volume - Still a Buy?NovoCure (NASDAQ:NVCR) Sees Strong Trading Volume - Still a Buy?June 4, 2025 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Given Consensus Rating of "Moderate Buy" by AnalystsShares of NovoCure Limited (NASDAQ:NVCR - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the six research firms that are currently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and four have assigned a buJune 4, 2025 | marketbeat.comNovoCure (NASDAQ:NVCR) Shares Down 8.2% - Should You Sell?NovoCure (NASDAQ:NVCR) Stock Price Down 8.2% - Should You Sell?June 3, 2025 | marketbeat.comResults From the Phase 3 PANOVA-3 Trial of Novocure’s Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual MeetingJune 2, 2025 | businesswire.comNovocure data support pancreatic cancer approval, says Wells FargoJune 2, 2025 | msn.comZai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual MeetingMay 31, 2025 | businesswire.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Lowers Stock Holdings in NovoCure Limited (NASDAQ:NVCR)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its stake in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 22.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7May 29, 2025 | marketbeat.com1 Stock Down 35% This Year You'll Regret Not Buying on the Dip, According to Wall StreetMay 28, 2025 | msn.comNovocure Announces Upcoming Investor EventsMay 27, 2025 | finance.yahoo.comNovoCure Limited (NASDAQ:NVCR) Shares Sold by Two Sigma Investments LPTwo Sigma Investments LP decreased its position in NovoCure Limited (NASDAQ:NVCR - Free Report) by 24.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 561,120 shares of the medical equipment providerMay 25, 2025 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Shares Sold by Voloridge Investment Management LLCVoloridge Investment Management LLC lessened its stake in NovoCure Limited (NASDAQ:NVCR - Free Report) by 15.4% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 870,155 shares of the medical equipment provider's stock after selling 158,270 shares during the quartMay 24, 2025 | marketbeat.comTwo Sigma Advisers LP Trims Stake in NovoCure Limited (NASDAQ:NVCR)Two Sigma Advisers LP cut its position in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 39.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 586,000 shares of the medical equipmenMay 24, 2025 | marketbeat.comNovoCure: Loading Up On Growth CatalystsMay 24, 2025 | seekingalpha.comBNP Paribas Financial Markets Sells 147,371 Shares of NovoCure Limited (NASDAQ:NVCR)BNP Paribas Financial Markets decreased its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 83.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 28,555 shares of the medical equipment provider's stock aftMay 24, 2025 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Holdings Boosted by Millennium Management LLCMillennium Management LLC boosted its position in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 28.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 735,227 shares of the medical equipment provider's stock afterMay 23, 2025 | marketbeat.comNovoCure Limited: Profitability Remains ElusiveMay 21, 2025 | seekingalpha.comSoleus Capital Management L.P. Takes Position in NovoCure Limited (NASDAQ:NVCR)Soleus Capital Management L.P. bought a new stake in NovoCure Limited (NASDAQ:NVCR - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 2,739,704 shares of the medical equipment provider'sMay 21, 2025 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Shares Acquired by Deutsche Bank AGDeutsche Bank AG grew its stake in NovoCure Limited (NASDAQ:NVCR - Free Report) by 20.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 194,327 shares of the medical equipment provider's stock afterMay 21, 2025 | marketbeat.comTeza Capital Management LLC Purchases 85,312 Shares of NovoCure Limited (NASDAQ:NVCR)Teza Capital Management LLC lifted its position in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 573.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 100,200 shares of the medical equipment proviMay 20, 2025 | marketbeat.comSilvercrest Asset Management Group LLC Decreases Stock Position in NovoCure Limited (NASDAQ:NVCR)Silvercrest Asset Management Group LLC cut its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 29.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 348,307 shares of the medical equipment pMay 20, 2025 | marketbeat.comQuantinno Capital Management LP Acquires 43,108 Shares of NovoCure Limited (NASDAQ:NVCR)Quantinno Capital Management LP increased its holdings in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 17.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 294,639 shares of the medical equipment provider's stock afteMay 18, 2025 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Shares Sold by Graham Capital Management L.P.Graham Capital Management L.P. reduced its holdings in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 59.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,709 shares of the medical equipmMay 17, 2025 | marketbeat.comLMR Partners LLP Buys Shares of 32,914 NovoCure Limited (NASDAQ:NVCR)LMR Partners LLP bought a new stake in NovoCure Limited (NASDAQ:NVCR - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 32,914 shares of the medical equipment provider's stock, valued at approximMay 16, 2025 | marketbeat.comNorthern Trust Corp Boosts Holdings in NovoCure Limited (NASDAQ:NVCR)Northern Trust Corp grew its position in NovoCure Limited (NASDAQ:NVCR - Free Report) by 39.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,284,350 shares of the medical equipment provider's stock afterMay 12, 2025 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Given Average Rating of "Moderate Buy" by AnalystsNovoCure Limited (NASDAQ:NVCR - Get Free Report) has earned an average recommendation of "Moderate Buy" from the six research firms that are currently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have issued a buMay 12, 2025 | marketbeat.comFrontier Capital Management Co. LLC Sells 145,096 Shares of NovoCure Limited (NASDAQ:NVCR)Frontier Capital Management Co. LLC decreased its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 16.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 726,324 shares of the medical equipment pMay 11, 2025 | marketbeat.comAlgert Global LLC Buys Shares of 69,261 NovoCure Limited (NASDAQ:NVCR)Algert Global LLC purchased a new position in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 69,261 shares of the medical equipment provider's stoMay 11, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Reduces Stock Position in NovoCure Limited (NASDAQ:NVCR)The Manufacturers Life Insurance Company trimmed its stake in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 24.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 152,602 shares of the medical equipment provider'sMay 11, 2025 | marketbeat.comCubist Systematic Strategies LLC Increases Position in NovoCure Limited (NASDAQ:NVCR)Cubist Systematic Strategies LLC lifted its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 223.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 335,218 shares of the medical equipment provider's stock after buying an adMay 10, 2025 | marketbeat.comBalyasny Asset Management L.P. Grows Stock Holdings in NovoCure Limited (NASDAQ:NVCR)Balyasny Asset Management L.P. boosted its stake in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 27.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,068,863 shares of the medical eqMay 9, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Takes Position in NovoCure Limited (NASDAQ:NVCR)Schonfeld Strategic Advisors LLC purchased a new stake in NovoCure Limited (NASDAQ:NVCR - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 105,280 shares of the medical equipment provider's stock, valued at approximately $May 6, 2025 | marketbeat.comPDT Partners LLC Trims Holdings in NovoCure Limited (NASDAQ:NVCR)PDT Partners LLC reduced its stake in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 28.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 80,232 shares of the medical equipment provider's stock after selling 31,8May 2, 2025 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Shares Sold by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD cut its position in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 27.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 1,683,818 shares of the medical equipment provider's stock after selling 638,37May 2, 2025 | marketbeat.comEmerald Mutual Fund Advisers Trust Makes New Investment in NovoCure Limited (NASDAQ:NVCR)Emerald Mutual Fund Advisers Trust bought a new stake in NovoCure Limited (NASDAQ:NVCR - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 325,255 shares of the medical equipment provider's stock, valuedMay 1, 2025 | marketbeat.com200,000 Shares in NovoCure Limited (NASDAQ:NVCR) Acquired by Adage Capital Partners GP L.L.C.Adage Capital Partners GP L.L.C. acquired a new position in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 200,000 shares of the medical equipment provider's stock, valued at apMay 1, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Trims Holdings in NovoCure Limited (NASDAQ:NVCR)T. Rowe Price Investment Management Inc. lowered its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 39.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 1,690,441 shares of the medical equipment provider's stock after selling 1,115,6April 28, 2025 | marketbeat.comInvesco Ltd. Acquires 79,698 Shares of NovoCure Limited (NASDAQ:NVCR)Invesco Ltd. grew its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 72.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 189,474 shares of the medical equipment provider's stock after purchasing an additional 79,698 shares durinApril 28, 2025 | marketbeat.comNovoCure (NASDAQ:NVCR) Cut to "Sell" at StockNews.comStockNews.com lowered NovoCure from a "hold" rating to a "sell" rating in a research note on Friday.April 27, 2025 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Q1 2025 Earnings Call TranscriptApril 25, 2025 | msn.comWhy NovoCure Stock Skyrocketed This WeekApril 25, 2025 | fool.comNovocure outlines expansion plans for lung cancer treatment and regulatory milestones in 2025April 25, 2025 | msn.comMarshall Wace LLP Has $8.07 Million Holdings in NovoCure Limited (NASDAQ:NVCR)Marshall Wace LLP lessened its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 65.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 270,952 shares of the medical equiApril 25, 2025 | marketbeat.comNovocure’s NSCLC launch momentum ‘positive,’ says H.C. WainwrightApril 24, 2025 | markets.businessinsider.comWhy NovoCure Stock Leaped 4% Higher TodayApril 24, 2025 | fool.comNovocure reports Q1 EPS (31c), consensus (46c)April 24, 2025 | markets.businessinsider.comNovoCure Warns Of Potential $11 Million Tariff Hit If US Trade Pause Expires In 2025April 24, 2025 | benzinga.com Get NovoCure News Delivered to You Automatically Sign up to receive the latest news and ratings for NVCR and its competitors with MarketBeat's FREE daily newsletter. Email Address NVCR Media Mentions By Week NVCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVCR News Sentiment▼0.660.87▲Average Medical News Sentiment NVCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVCR Articles This Week▼65▲NVCR Articles Average Week Get NovoCure News Delivered to You Automatically Sign up to receive the latest news and ratings for NVCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Stevanato Group News Glaukos News TransMedics Group News iRhythm Technologies News Inari Medical News Bausch + Lomb News Inspire Medical Systems News Soleno Therapeutics News PROCEPT BioRobotics News Envista News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVCR) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovoCure Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NovoCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVCR Stock Free NVCR Stock Alerts